Anticoagulant drugs with or without proton pump inhibitor and colorectal cancer risk: a population-based, case–control study

Abstract Background Low-dose aspirin and clopidogrel have demonstrated potential chemoprevention for colorectal cancer (CRC). Proton-pump inhibitors (PPI) are commonly prescribed with anticoagulation drugs, but the relationship between PPI and CRC is unclear. Moreover, evidence of CRC risk under dir...

Descrición completa

Detalles Bibliográficos

Principais autores:	Pei-Huan Ho, Hung-Chun Hsiao, Chun-Wei Chen, Hui-Ming Chen, Siew-Na Lim, Chau-Ting Yeh, Chia-Jung Kuo, Wey-Ran Lin
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2022-05-01
Series:	BMC Gastroenterology
Assuntos:	Colorectal cancer Low-dose aspirin Clopidogrel Direct oral anticoagulant Proton pump inhibitor
Acceso en liña:	https://doi.org/10.1186/s12876-022-02314-w
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!